Atlas Trials

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Clinical trial NCT06594640 · RECRUITING

Trial details

NCT number
NCT06594640
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2024-05-30
Primary completion
2026-06-30
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.